Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 16

1.

The risk of recurrent venous thromboembolism in men and women.

Kyrle PA, Minar E, Bialonczyk C, Hirschl M, Weltermann A, Eichinger S.

N Engl J Med. 2004 Jun 17;350(25):2558-63.

2.

Oral contraceptives, hormone replacement therapy, thrombophilias and risk of venous thromboembolism: a systematic review. The Thrombosis: Risk and Economic Assessment of Thrombophilia Screening (TREATS) Study.

Wu O, Robertson L, Langhorne P, Twaddle S, Lowe GD, Clark P, Greaves M, Walker ID, Brenkel I, Regan L, Greer IA.

Thromb Haemost. 2005 Jul;94(1):17-25. Review.

PMID:
16113779
3.

[Duration of oral anticoagulant therapy in venous thromboembolism].

Pinède L.

Rev Med Interne. 2001 Dec;22(12):1225-36. Review. French.

PMID:
11794893
4.

The risk of recurrent venous thromboembolism: the Austrian Study on Recurrent Venous Thromboembolism.

Kyrle PA, Eichinger S.

Wien Klin Wochenschr. 2003 Aug 14;115(13-14):471-4. Review.

PMID:
13677265
5.

Effect of patient's sex on risk of recurrent venous thromboembolism: a meta-analysis.

McRae S, Tran H, Schulman S, Ginsberg J, Kearon C.

Lancet. 2006 Jul 29;368(9533):371-8. Review.

PMID:
16876665
6.

Treatment of DVT: how long is enough and how do you predict recurrence.

Agnelli G, Becattini C.

J Thromb Thrombolysis. 2008 Feb;25(1):37-44. Epub 2007 Oct 1. Review.

PMID:
17906973
7.

Factor V Leiden mutation and the risks for thromboembolic disease: a clinical perspective.

Price DT, Ridker PM.

Ann Intern Med. 1997 Nov 15;127(10):895-903. Review.

PMID:
9382368
8.

Risk of recurrence after venous thromboembolism in men and women: patient level meta-analysis.

Douketis J, Tosetto A, Marcucci M, Baglin T, Cosmi B, Cushman M, Kyrle P, Poli D, Tait RC, Iorio A.

BMJ. 2011 Feb 24;342:d813. doi: 10.1136/bmj.d813. Review.

9.

Oral anticoagulant therapy in venous thromboembolism.

Cosmi B, Palareti G.

Semin Vasc Med. 2003 Aug;3(3):303-14. Review.

PMID:
15199464
10.

[The optimal duration of anticoagulant treatment following pulmonary embolism].

Couturaud F.

Rev Mal Respir. 2011 Dec;28(10):1265-77. doi: 10.1016/j.rmr.2011.04.017. Epub 2011 Nov 3. Review. French.

PMID:
22152935
11.

Recurrent venous thromboembolism: diagnosis and management.

Huisman MV.

Curr Opin Pulm Med. 2000 Jul;6(4):330-4. Review.

PMID:
10912642
12.

Current management of acute symptomatic deep vein thrombosis.

Heit JA.

Am J Cardiovasc Drugs. 2001;1(1):45-50. Review.

PMID:
14728051
13.

Sex and gender issues and venous thromboembolism.

Moores L, Bilello KL, Murin S.

Clin Chest Med. 2004 Jun;25(2):281-97. Review.

PMID:
15099889
14.

Long-term treatment for venous thromboembolism.

Couturaud F, Kearon C.

Curr Opin Hematol. 2000 Sep;7(5):302-8. Review.

PMID:
10961581
15.

Posttreatment ultrasound-detected residual venous thrombosis: a risk factor for recurrent venous thromboembolism and mortality.

Savory L, Harper P, Ockelford P.

Curr Opin Pulm Med. 2007 Sep;13(5):403-8. Review.

PMID:
17940485
16.

Patient-level meta-analysis: effect of measurement timing, threshold, and patient age on ability of D-dimer testing to assess recurrence risk after unprovoked venous thromboembolism.

Douketis J, Tosetto A, Marcucci M, Baglin T, Cushman M, Eichinger S, Palareti G, Poli D, Tait RC, Iorio A.

Ann Intern Med. 2010 Oct 19;153(8):523-31. doi: 10.7326/0003-4819-153-8-201010190-00009. Review.

PMID:
20956709

Supplemental Content

Support Center